Biotechnology
Compare Stocks
2 / 10Stock Comparison
ELAB vs AEYE
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
ELAB vs AEYE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Software - Application |
| Market Cap | $49K | $100M |
| Revenue (TTM) | $-1M | $40M |
| Net Income (TTM) | $-7M | $-3M |
| Gross Margin | 72.8% | 78.3% |
| Operating Margin | -75.7% | -7.9% |
| Total Debt | $0.00 | $721K |
| Cash & Equiv. | $4M | $5M |
ELAB vs AEYE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 23 | May 26 | Return |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | 100 | 0.0 | -100.0% |
| AudioEye, Inc. (AEYE) | 100 | 189.5 | +89.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ELAB vs AEYE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ELAB is the clearest fit if your priority is growth exposure.
- Rev growth 44.1%, EPS growth 86.0%, 3Y rev CAGR 13.4%
- 44.1% revenue growth vs AEYE's 14.5%
AEYE carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 1 yrs, beta 2.29
- 102.2% 10Y total return vs ELAB's -100.0%
- Lower volatility, beta 2.29, Low D/E 15.0%, current ratio 0.88x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 44.1% revenue growth vs AEYE's 14.5% | |
| Quality / Margins | -7.6% margin vs ELAB's -253.1% | |
| Stability / Safety | Beta 2.29 vs ELAB's 4.01 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -27.9% vs ELAB's -99.7% | |
| Efficiency (ROA) | -9.5% ROA vs ELAB's -44.6%, ROIC -42.4% vs -82.7% |
ELAB vs AEYE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ELAB vs AEYE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
AEYE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AEYE and ELAB operate at a comparable scale, with $40M and -$1M in trailing revenue. Profitability is closely matched — net margins range from -7.6% (AEYE) to -2.5% (ELAB). On growth, AEYE holds the edge at +7.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | -$1M | $40M |
| EBITDAEarnings before interest/tax | -$4M | -$504,000 |
| Net IncomeAfter-tax profit | -$7M | -$3M |
| Free Cash FlowCash after capex | -$7M | $2M |
| Gross MarginGross profit ÷ Revenue | +72.8% | +78.3% |
| Operating MarginEBIT ÷ Revenue | -75.7% | -7.9% |
| Net MarginNet income ÷ Revenue | -2.5% | -7.6% |
| FCF MarginFCF ÷ Revenue | -2.2% | +5.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -45.8% | +7.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | +29.0% |
Valuation Metrics
ELAB leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $49,114 | $100M |
| Enterprise ValueMkt cap + debt − cash | -$4M | $96M |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -32.36x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.02x | 2.49x |
| Price / BookPrice ÷ Book value/share | 0.01x | 20.91x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
AEYE leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
AEYE delivers a -47.8% return on equity — every $100 of shareholder capital generates $-48 in annual profit, vs $-78 for ELAB.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -78.4% | -47.8% |
| ROA (TTM)Return on assets | -44.6% | -9.5% |
| ROICReturn on invested capital | -82.7% | -42.4% |
| ROCEReturn on capital employed | -33.7% | -17.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 |
| Debt / EquityFinancial leverage | — | 0.15x |
| Net DebtTotal debt minus cash | -$4M | -$5M |
| Cash & Equiv.Liquid assets | $4M | $5M |
| Total DebtShort + long-term debt | $0 | $721,000 |
| Interest CoverageEBIT ÷ Interest expense | -17.68x | -2.79x |
Total Returns (Dividends Reinvested)
AEYE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AEYE five years ago would be worth $3,977 today (with dividends reinvested), compared to $0 for ELAB. Over the past 12 months, AEYE leads with a -27.9% total return vs ELAB's -99.7%. The 3-year compound annual growth rate (CAGR) favors AEYE at 6.4% vs ELAB's -98.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -98.4% | -18.7% |
| 1-Year ReturnPast 12 months | -99.7% | -27.9% |
| 3-Year ReturnCumulative with dividends | -100.0% | +20.6% |
| 5-Year ReturnCumulative with dividends | -100.0% | -60.2% |
| 10-Year ReturnCumulative with dividends | -100.0% | +102.2% |
| CAGR (3Y)Annualised 3-year return | -98.7% | +6.4% |
Risk & Volatility
AEYE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AEYE is the less volatile stock with a 2.29 beta — it tends to amplify market swings less than ELAB's 4.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AEYE currently trades 49.4% from its 52-week high vs ELAB's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.01x | 2.29x |
| 52-Week HighHighest price in past year | $1236.48 | $16.39 |
| 52-Week LowLowest price in past year | $1.62 | $5.31 |
| % of 52W HighCurrent price vs 52-week peak | +0.2% | +49.4% |
| RSI (14)Momentum oscillator 0–100 | 36.7 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 10.4M | 194K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
AEYE leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ELAB leads in 1 (Valuation Metrics).
ELAB vs AEYE: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ELAB or AEYE a better buy right now?
For growth investors, PMGC Holdings Inc.
(ELAB) is the stronger pick with 44. 1% revenue growth year-over-year, versus 14. 5% for AudioEye, Inc. (AEYE). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ELAB or AEYE?
Over the past 5 years, AudioEye, Inc.
(AEYE) delivered a total return of -60. 2%, compared to -100. 0% for PMGC Holdings Inc. (ELAB). Over 10 years, the gap is even starker: AEYE returned +102. 2% versus ELAB's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ELAB or AEYE?
By beta (market sensitivity over 5 years), AudioEye, Inc.
(AEYE) is the lower-risk stock at 2. 29β versus PMGC Holdings Inc. 's 4. 01β — meaning ELAB is approximately 75% more volatile than AEYE relative to the S&P 500.
04Which is growing faster — ELAB or AEYE?
By revenue growth (latest reported year), PMGC Holdings Inc.
(ELAB) is pulling ahead at 44. 1% versus 14. 5% for AudioEye, Inc. (AEYE). On earnings-per-share growth, the picture is similar: PMGC Holdings Inc. grew EPS 86. 0% year-over-year, compared to 30. 6% for AudioEye, Inc.. Over a 3-year CAGR, ELAB leads at 1340% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ELAB or AEYE?
AudioEye, Inc.
(AEYE) is the more profitable company, earning -7. 6% net margin versus -253. 1% for PMGC Holdings Inc. — meaning it keeps -7. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AEYE leads at -7. 9% versus -75. 7% for ELAB. At the gross margin level — before operating expenses — AEYE leads at 78. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ELAB or AEYE?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is ELAB or AEYE better for a retirement portfolio?
For long-horizon retirement investors, AudioEye, Inc.
(AEYE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+102. 2% 10Y return). PMGC Holdings Inc. (ELAB) carries a higher beta of 4. 01 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AEYE: +102. 2%, ELAB: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ELAB and AEYE?
These companies operate in different sectors (ELAB (Healthcare) and AEYE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ELAB is a small-cap high-growth stock; AEYE is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.